Venkatakrishna Rao Jala
Overview
Explore the profile of Venkatakrishna Rao Jala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghosh S, Singh R, Goap T, Sunnapu O, Vanwinkle Z, Li H, et al.
J Nanobiotechnology
. 2024 Nov;
22(1):701.
PMID: 39533380
Inflammatory bowel disease (IBD) treatment often involves systemic administration of anti-inflammatory drugs or biologics such as anti-TNF-α antibodies. However, current drug therapies suffer from limited efficacy due to unresponsiveness and...
2.
Wechman S, Jala V, Bermudez-Humaran L, Gomez-Gutierrez J
Front Immunol
. 2024 Mar;
15:1386574.
PMID: 38455064
No abstract available.
3.
Ghosh S, Erickson D, Chua M, Collins J, Jala V
mSystems
. 2024 Jan;
9(2):e0125523.
PMID: 38193707
is a Gram-positive, anaerobic, spore-forming bacterium responsible for antibiotic-associated pseudomembranous colitis. infection (CDI) symptoms can range from diarrhea to life-threatening colon damage. Toxins produced by (TcdA and TcdB) cause intestinal...
4.
Ghosh S, Erickson D, Chua M, Collins J, Jala V
bioRxiv
. 2023 Aug;
PMID: 37546803
is a gram-positive, anaerobic, spore-forming bacterium that is responsible for antibiotic-associated pseudomembranous colitis. infection (CDI) symptoms can range from diarrhea to life-threatening colon damage. Toxins produced by (TcdA and TcdB)...
5.
Juin S, Ouseph R, Gondim D, Jala V, Sen U
Antioxidants (Basel)
. 2023 May;
12(5).
PMID: 37237955
Diabetic nephropathy (DN) remains the leading cause of vascular morbidity and mortality in diabetes patients. Despite the progress in understanding the diabetic disease process and advanced management of nephropathy, a...
6.
Ghosh S, Moorthy B, Haribabu B, Jala V
Front Immunol
. 2022 Sep;
13:1004603.
PMID: 36159798
Background: Cytochrome P450 Family 1 Subfamily A Member 1 (CYP1A1) pathway, which is regulated by aryl hydrocarbon receptor (AhR) plays an important role in chemical carcinogenesis and xenobiotic metabolism. Recently,...
7.
Mehra S, Srinivasan S, Singh S, Zhou Z, Garrido V, De Castro Silva I, et al.
Am J Physiol Gastrointest Liver Physiol
. 2022 Sep;
323(4):G375-G386.
PMID: 36098401
Heavy alcohol consumption is the dominant risk factor for chronic pancreatitis (CP); however, treatment and prevention strategies for alcoholic chronic pancreatitis (ACP) remains limited. The present study demonstrates that ACP...
8.
Ghosh S, Singh R, Vanwinkle Z, Guo H, Vemula P, Goel A, et al.
Theranostics
. 2022 Aug;
12(12):5574-5595.
PMID: 35910798
The survival rate of colorectal cancer patients is adversely affected by the selection of tumors resistant to conventional anti-cancer drugs such as 5-fluorouracil (5FU). Although there is mounting evidence that...
9.
Ghosh S, Banerjee M, Haribabu B, Jala V
Arch Toxicol
. 2022 Feb;
96(4):987-1007.
PMID: 35122514
Environmental chemicals such as inorganic arsenic (iAs) significantly contribute to redox toxicity in the human body by enhancing oxidative stress. Imbalanced oxidative stress rapidly interferes with gut homeostasis and affects...
10.
Ghosh S, Whitley C, Haribabu B, Jala V
Cell Mol Gastroenterol Hepatol
. 2021 Feb;
11(5):1463-1482.
PMID: 33610769
The human gastrointestinal tract (GI) harbors a diverse population of microbial life that continually shapes host pathophysiological responses. Despite readily available abundant metagenomic data, the functional dynamics of gut microbiota...